and coronary vasodilator effects of gentamicin (GM) were investigated in isolated, blood-perfused papillary muscle, sino-atrial (SA) node and atrioventricular (AV) node preparations of dogs. GM (0.3-100 "mol) was injected intraarterially.
Abstract-Cardiac
and coronary vasodilator effects of gentamicin (GM) were investigated in isolated, blood-perfused papillary muscle, sino-atrial (SA) node and atrioventricular (AV) node preparations of dogs. GM (0.3-100 "mol) was injected intraarterially.
GM produced an increase in coronary blood flow in all preparations. In paced papillary muscle preparations, GM reduced the force of contraction.
In spontaneously beating papillary muscle preparations, GM decreased the rate of automaticity and the force of contraction.
In SA node preparations, GM decreased the sinus rate. In AV node preparations, GM injected into the posterior septal artery (which supplies the AV node) increased AV conduction time and in large doses, produced third-degree AV block.
In the same preparations, GM in large doses injected into the anterior septal artery (which supplies the His-Purkinje ventricular system) prolonged AV conduction time (i.e., intraventricular conduction time) and reduced the amplitude of ventricular bipolar electrograms.
The order of potencies of GM on the above cardiovascular variables is as follows: Coronary blood flow>_ventricular muscle contraction>ventricular automaticity>SA nodal automaticity>AV nodal conduction>intraventricular conduction. This cardio vascular profile is different from those of organic calcium-antagonists, but rather similar to that of manganese ions, reflecting its own mechanism of action.
Organic calcium antagonists (hereafter simply called Ca-antagonists) such as pre nylamine and verapamil were initially thought to compete with calcium ions (Ca2+) for the same site at Ca-channels to interfere with Ca 21-influx or at the contractile ma chinery in cardiac muscle (1). At present, however, Ca-antagonists are understood to modulate Ca-channels in such a way as to cause them to remain in the closed state by binding to specific sites at Ca-channels which are different from the Ca2+-binding sites (2-5).
Ca-antagonists are pharma cologically differentiated into two groups: One is selective for vasculature, being re presented by the dihydropyridine Ca antagonist nifedipine, and the other does not discriminate between vasculature and cardiac musculature, being represented by verapamil (6, 7).
Aminoglycosides
have long been known to have hypotensive (8-10) and negative inotropic (8, 10, 11) actions in addition to neuromuscular blocking action (8, 9, 12). Since these actions were reversed by Ca2+, interference of aminoglycosides with the function of Ca2+ was suggested as the mecha nism of action (9, 11, 12) . Afterwards, the hypothesis on the mechanism of action of aminoglycosides has been extended to sug gest that at least at the prejunctional mem brane in the motor end-plate, aminoglycoside molecules compete with Ca2+ for binding sites presumably located near the outer orifice of Ca-channels to impede the Ca" influx (13, 14) . If aminoglycosides act so at the plasma membrane of vascular smooth and cardiac muscle, the mechanism for the Ca2+ entry blocking action of aminoglycosides is different from those of Ca-antagonists.
Thus, it was of interest to know how the cardiovascular profiles of aminoglycosides are different from those of Ca-antagonists. The present experiments were performed for this purpose. Since GM has clearly been demonstrated in guinea-pig ventricular muscle to block the inward Cat+-current (15), this aminoglycoside was chosen for this study.
Materials and Methods

Preparations
The following preparations were obtained from mongrel dogs of either sex weighing 7 13 kg. The animals were anesthetized with sodium pentobarbital (30 mg/kg, i.v.), given calcium heparin (500 U/kg, i.v.), and ex sanguinated. All the preparations were placed in funnel-shaped glass water-jackets warmed at about 38°C. They were cross-circulated with donor dogs through the cannulated nutrient arteries. Arterial blood was with drawn from the carotid artery of the donors by virtue of a peristaltic pump (Harvard Apparatus, model 1215) and delivered to the preparations.
Constant pressure perfusion was performed with a pump speed controller (Data Graph, SCS-22).
Papillary muscle preparation: The papillary muscle preparation was essentially the an terior papillary muscle of the right ventricle taken together with the ventricular septum. The preparation was fixed to a plastic plate with a hole in which the papillary muscle was fitted at the base. The preparation was perfused through the cannulated anterior septal artery (ASA) with arterial blood at a constant pressure of about 100 mmHg (16 (18) . The preparation was perfused through can nulas placed in the RCA, the posterior septal artery (PSA) and the ASA with arterial blood from a donor dog at a constant pressure of about 120 mmHg. This higher perfusion pressure secured perfusion of the AV node whose function is susceptible to anoxia (18) . The right atrium was paced with rectangular pulses of 1 msec duration and about twice the threshold voltage at a rate of 150 stimuli/ min through bipolar stimulating electrodes sutured on the endocardium of the crista terminalis. This stimulation rate was needed to prevent the fixed pacing rate from being overridden by spontaneous rhythms oc curring in the SA node or other regions. However, up to this rate, normal AV con duction time was obtainable (18) . Atrial bipolar electrograms were obtained from an area near the coronary sinus and ventricular bipolar electrograms from an area between the AV ring and anterior papillary muscle of the right ventricle. Both electrograms were fed into an AV interval meter (Data Graph, HN-110), which measured AV conduction time at a resolution of 1 msec. The ven tricular recording electrodes often picked up bipolar electrograms of the right bundle branch (B) together with those of the underlying ventricular myocardium (V). In such cases, the B-V interval as an estimate of drug effect on intraventricular conduction was also measured from records on Polaroid film. In each preparation, blood flow through its nutrient artery was measured with an electromagnetic flow meter (Nihon Kohden, MF-26). All measured variables were re corded on charts with a rectilinear pen recorder (San-ei Instrument, 8S). Bipolar electrograms were amplified by RC amplifiers with a time constant of 0.1 sec (high fre quency components were not cut), moni tored on an oscilloscope (Nihon Kohden, VC-9) and recorded on Polaroid film when necessary.
Mongrel dogs of either sex weighing 13 28 kg were used as donors. They were anes thetized with sodium pentobarbital initially at a dose of 30 mg/kg, i.v., and later at supplemental doses when necessary. They were also given calcium heparin initially at a doses of 500 U/kg, i.v., and later at hourly doses of 100-200 U/kg, i.v. Drugs Gentamicin sulfate (Shionogi) was dis solved in distilled water to give a concen tration of 333 ,umol/ml (nearly the highest concentration at which it can be dissolved). Solutions of GM at the desired concentrations were obtained by dilution of the stock solution with 0.9% saline. Drug solutions were injected into the nutrient artery in each preparation in a constant volume of 30 al (in 4 sec), 90 flI (in 10 sec for 30 umol of GM), or 300 el (in 30 sec for 100 icmol of GM) by use of microsyringes. The solvent of GM had virtually no effect on any of the variables measured. Statistical analysis Basal values were expressed in terms of the mean±S.E.
All changes in blood flow and cardiac variables were expressed as percen tages of the respective basal values. Doses producing certain changes in blood flow or cardiac variables were determined from dose response curves fitted by linear regressions, and they were given with confidence limits for 0.95 probability in brackets. Results Effects on developed tension of the papillary muscle and on blood flow through the ASA: The basal ASA flow of seven papillary muscles stimulated at the rate of 120 stimuli/min was 5.4±1.2 ml/min, and the basal developed tension was 5.6±0.7 g. Single injections of GM (0.3-100 umol) into the ASA produced an increase in ASA flow and a decrease in developed tension in a dose-dependent manner. In Fig. 1 is shown a typical experiment and in Fig. 2 are pre sented the dose-response curves for increase in ASA flow (upper panel) and decrease in developed tension (lower panel). At 100 ,amol, ASA flow increased by about 270% and developed tension decreased down to about 5% of the respective basal values. The negative inotropic and vasodilator effects were short-lived and occurred in mirror image. The dose that doubled ASA flow was very close to the dose that reduced developed tension by half the basal value: 13.9 [7.7 20.1 ] iimol for the former against 14.9 [9.4 20.4] amol for the latter.
Effects on rate of automaticity and de veloped tension of the spontaneously beating papillary muscle: Experiments were performed on six other papillary muscle preparations beating spontaneously.
This ventricular auto maticity is thought to originate in Purkinje fibers in the ventricular septum (19) . The basal rate was 39±1 beats/min and the basal developed tension was 3.9±0.3 g. GM (3 100 itmol) injected into the ASA reduced the rate of automaticity and developed tension in a dose-dependent manner, and at 100 rimol, the rate of automaticity decreased by about 34% and developed tension by about 88% of the respective basal values (Figs. 3 and 4) . The dose that produced a 17% decrease in ventricular rate (the dose that produced nearly a half maximum decrease in ven tricular rate) was 20.2 [12.1-35.5] /imol. Effects on sinus rate and on blood flow through the RCA: In seven SA node pre parations, the basal blood flow through the RCA was 3.4±0.4
ml/min at a constant pressure of about 100 mmHg, and the basal sinus rate was 93±3 beats/min. Single bolus injections of GM (1-100 iimol) into the RCA produced a short-lived but dose dependent increase in RCA flow (Fig. 5) , and the dose that doubled RCA flow was 46.4 [28.5-101 ] /rmol. In large doses (3-100 ,umol), GM produced a short-lived but dose dependent decrease in sinus rate, and at 100 /cmol, sinus rate decreased by about 35% of its basal value (Figs. 5 and 6 ). The dose that produced a 17% decrease in sinus rate (the dose that produced nearly a half maxi mum decrease in sinus rate) was 19.4 [12.1 32.0] /cmol. Effects on AV nodal and intraventricular conduction and on blood flow through the PSA and ASA: I n seven AV node pre parations, the basal AV conduction time was 134±5 msec at a pacing rate of 150 stimuli/ min. When injected into the PSA, GM (0.3 100 /tmol) increased AV conduction time in a dose-dependent manner, and at 100 /imol, third-degree AV block which lasted about 30 sec at the longest occurred in three of the seven preparations. In these three pre parations, AV conduction time had in creased up to about 210 msec (the increase was about 56% of its basal value) before ventricular bipolar electrograms failed to follow atrial ones, and these increases were deemed to be maximum. In Fig. 7 is shown a typical experiment and in Fig. 8 ) ). However, the increase was so small that it failed to reach the half maximum in crease produced by intra-PSA GM. As to the effect on AV conduction time, GM was roughly 1/5 as effective when injected into the ASA as when injected into the PSA.
The increase in AV conduction time by GM injected into the ASA was accompanied by a small prolongation of the B-V interval (Fig. 9) . On the other hand, the B-V interval remained unchanged when GM was injected into the PSA (data are not shown). Fur thermore, unlike the case with intra-PSA injection, when GM was injected into the ASA, there occurred a small but definite reduction of the amplitude of ventricular bipolar electrograms.
Taking together with the anatomical finding that the PSA pre dominantly supplies the AV node but the ASA supplies the His Purkinj'e-ventricular system, these results indicate that an increase in AV conduction time produced by GM injected into the ASA reflected an increase in intraventricular conduction time. The basal blood flow through the PSA and ASA was 7.6+1.2 and 8.4+1.2 ml/min, respectively, at a constant perfusion pressure of about 120 mmHg. With GM (0.3-100 ,tmol) injected into the PSA and ASA, blood flow through each artery increased in a dose-dependent manner, and in large doses, these flows increased to more than twice the respective basal flow. The dose that doubled PSA flow was 27.3 [17.2-41.1] icmol. Table 1 and figured as the selectivity spectrum in Fig. 10 . 
Discussion
In the present experiments, GM increased coronary blood flow and reduced the force of contraction of the ventricular myo cardium (the papillary muscle) and sinus rate in the dog heart. The present results are thus consistent with those of previous in vestigators, i.e., hypotension (due to vasodi latation) (8-10, 20), reduction of vascular resistance (10), relaxation of vascular smooth muscle (21, 22) , reduction of the force of contraction of cardiac muscle (10, 11, 20, 23, 24) and bradycardia (20) . The present experiments further disclosed that GM impairs AV nodal conduction. These effects of GM are understandable if GM unanimously impairs the inward Ca2+-current in vascular smooth muscle, ventricular muscle, SA node and AV node cells, as has been demonstrated by voltage-clamp experi ments on guinea-pig papillary muscles (15). The mechanisms underlying the impair ment by aminoglycosides .of the inward Ca2+-current so far are thought to be different from those of Ca-antagonists. The mechanism of action of Ca-antagonists is understood to be as follows: They bind to their specific binding sites at Ca-channels so that the channels remain in the closed state (2-5). The binding characteristics (binding kinetics, sites, etc.) greatly differ between non-dihydropyridine and dihydro pyridine Ca-antagonists, and the binding is also influenced by membrane potentials (2 5). Unlike Ca-antagonists, aminoglycosides are thought to impair the Cat+-influx by competing with Ca2+ for Cat+-binding sites presumably located at the outer orifice of Ca channels (13, 14) or displacing Ca 21 from the superficial layer of the plasma membrane in such a way as to reduce available Ca2+ for the transmembrane influx (23, 24) . Thus, it can be expected that aminoglycosides far less discriminate between cardiac and vascular smooth muscle than Ca-antagonists. As can be clearly seen in Fig. 10 , GM was as potent in dilating coronary vasculature as in inhibiting the force of contraction of the ventricular myocardium. Non-dihydropyridine Ca-antagonists such as verapamil and dil tiazem are known to fail to discriminate between vascular smooth and cardiac muscle (6, 7). Nevertheless, verapamil is nearly 3.5 times and diltiazem is nearly 5 times as potent in producing coronary vasodilatation as in producing negative inotropy (6, 25). Thus, if the equi-potency of GM on coronary vasculature and ventricular myocardium is understood as an expression of the indiscriminate effect of GM on vascular smooth and ventricular muscle, it can be stated that even non-vasoselective, non dihydropyridine Ca-antagonists discriminate between vascular smooth and ventricular muscle. Unlike verapamil and diltiazem that are nearly equi-potent in reducing sinus rate, in prolonging AV nodal conduction time and in increasing coronary blood flow (6, 7), GM was nearly half as potent in reducing sinus rate and in prolonging AV nodal con duction time as in increasing coronary blood flow. If such effects of GM are naively taken as an expression of its 1ndiscriminative action on vascular smooth muscle and nodal cells of the heart, non-dihydropyridine Ca-antagonists can be understood as having a preference for nodal cells over vascular smooth muscle.
The most surprising thing revealed in the present experiments is that GM suppressed ventricular automaticity. This automaticity is thought to be an expression of that of Purkinje fibers in the ventricular septum to which the papillary muscle is attached (19) . The virtual absence of effects on this auto maticity is thought to be characteristic of Ca antagonists (6, 7, 26) . In Purkinje fibers, the pacemaker current is carried by sodium (Na+) and potassium (K+) ions in the inward direction and called If (27, 28) . However, at present, no information is available about whether this current is not affected by Ca antagonists. In the present experiments, also, no attempt was made to investigate what kinds of ionic currents were affected by GM in the Purkinje fibers of the dog heart. Available information indicates that GM inhibits the inward Cat'-current (15). However, suppression by GM of the auto maticity of Purkinje fibers is by no means explainable by the blockade of the inward Cat+-current.
Here it can be recalled that manganese ions (Mn2+) were effective in suppressing ventricular automaticity of the same kind of preparations that were used in the present experiments (19) . Needless to say, Mn2+ suppresses the force of con traction of cardiac muscle (19, 29) , causes bradycardia (30) , impairs AV nodal con duction (31, 32) and dilates vasculature (19) . Thus, the observed effects of GM closely resemble those of Mn2+. The mecha nism of action responsible for these effects of Mn2+, except for the suppressant effect on ventricular automaticity, is the blockade of the inward Ca 2+-current by competition with Ca2+ for Ca2+ binding sites at Ca-channels (33) . However, no electrophysiological ex planation is available for the suppressant effect of Mn2+ on automaticity of Purkinje fibers. Conversely, Mn2+ has been used to improve the resolution of the 1, time course by eliminating the inward Ca2+ current (34), suggesting no inhibitory effects on If.
In the present experiments, GM, although in very large doses, reduced the amplitude of ventricular bipolar electrograms and pro longed B-V interval as a measure of intra ventricular conduction, reflecting the block ade of the fast Na '-current. Impermeant monovalent cations such as methylguanidi nium ions have been known to reduce the fast Na+-current in the axonal membrane (35) . The reduction of the fast Na+-current by methylguanidinium ions has been ex plained in such a way that they can reach negatively charged Na+ binding sites far into Na+-channels but can not move into the narrow selective filters there (35) . GM molecules as polyvalent cations would likely act in a similar way to methylguanidinium ions at the Na+-channels of the cardiac cell membrane, so that intraventricular con duction was slowed down and the amplitude of ventricular bipolar electrograms was re duced. A similar mechanism would also operate in putative If-channels or Na+ channels in the cell membrane of Purkinje fibers so that their automaticity was de pressed.
In short, the cardiovascular profile of GM differed definitely not only from non-vaso selective, non-dihydropyridine Ca-antago nists but also from vasoselective dihydro pyridine Ca-antagonists.
Thus, the difference in mechanism of action appear to be re flected in the difference in cardiovascular profile. 
